The Buerger’s Disease Market is anticipated to reach USD 592.6 Million by 2030 at 5.9% CAGR during the forecast period 2022-2030.
Buerger’s disease is also known as thromboangiitis obliterans (TAO). Buerger’s disease is a rare and severe disease of veins and arteries especially in arms and legs. In this disease, blockage of blood vessels of hands and feet occurs in this disease condition. Blood clots or thrombi obstruct the blood vessels, resultantly, the blood vessels become inflamed and swell which reduces the blood flow.
This leads to the destruction or damage of skin tissues that may cause gangrene and other infections. The exact causes of this disease are unknown but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud's phenomenon etc. There is no 100% cure for this disease.
Considering the market scenario of Buerger’s disease, some important factors are driving the growth for this market one of them is increasing investment in research, development of new therapies and clinical trials. Approvals for new treatments or therapies plays vital role in the growth of this market.
In 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger's Disease. Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger's disease. Introduction and adoption of advanced diagnostic medical devices are another key drivers for the Buerger’s disease market growth.
Some of the key players in this market are:
Buerger’s disease market has been segmented on the basis of diagnosis which comprise of blood tests, The Allen's test, angiogram, tissue biopsy, and others. Angiogram is further sub-segmented into CT scan (Computerized Tomography), MRI (Magnetic Resonance Imaging) Scan, X-rays, and others.
On the basis of treatments, the market has been segmented into smoking cessation, and other treatments. Other treatments is further sub-segmented into medications, intermittent compression of the arms and legs, spinal cord stimulation, surgery, amputation, therapeutic angiogenesis, and others. Medication includes medications to dilate blood vessels, medications to improve blood flow, medications to dissolve blood clots, and others.
On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.
Research Methodology:
Regional analysis of Buerger’s disease market:
Considering the global scenario of the market, the Americas are holding the largest market for Buerger’s disease. The Americas mainly include North America and Latin America, out of which North America is holding majority of market share of this region. US is the top revenue generating market in North America and is one of the important markets for Buerger’s disease. Various factors are leading the market growth such as availability of funding for research and clinical trials, and advanced diagnostic and treatment options. Latin America Buerger’s disease market is also growing significantly and mainly includes Brazil, Argentina and Chile.
Europe is the second largest and one of the important markets for Buerger’s disease. Increasing cases of Buerger’s disease is a key driving factor for this market. Europe is mainly divided into Eastern Europe and Western Europe.
More developed western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Asia Pacific region is showing the fastest growth rate in Buerger’s disease market due to some major factors such as increasing awareness of the disease and related care, increasing investment in research, and rapidly improving healthcare facilities. China is holding major market share while India market is expected to have fastest growth in this region. Governments of different Asia nations are taking various initiatives to increase awareness of this disease that plays important role in the growth of this market.
Middle East & Africa is expected to have a limited growth due to lack of knowledge of disease, traditional healthcare practices etc. Middle East region is dominating this market due to some major factors like developed healthcare facilities and government support to improve public health.
Intended Audience:
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 592.6 Million |
| Â Â CAGR | Â Â 5.9% (2022-2030) |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2022-2030 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Value (USD Million) |
| Â Â Report Coverage | Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Diagnosis, Treatment, and End Users |
| Â Â Geographies Covered | Â Â Americas, Europe, Asia-Pacific, and the Middle East & Africa |
| Â Â Key Vendors | Â Â FUJIFILM Holdings Corporation (Japan), General Electric Company (US), Koninklijke Philips N.V. (the Netherlands), pluristem (Israel), Shimadzu Corporation (Japan), Siemens Healthcare GmbH (Germany), STEMPEUTICS RESEARCH PVT LTD (India) Toshiba Medical Corporation (Japan), t2cure GmbH (Germany), and others |
| Â Â Key Market Opportunities | Â Â Increasing investment in research, development of new therapies and clinical trials |
|   Key Market Drivers |   Approvals for new treatments or therapies and introduction and adoption of advanced diagnostic medical devices |
Buergers Disease Market Highlights:
Frequently Asked Questions (FAQ) :
Buerger’s disease market is expected to exhibit a CAGR of 5.9% from 2022 to 2030.
Buerger’s disease market valuation can touch USD 592.6 Million by 2030.
Investment in clinical trials for testing the efficacy of treatment drugs is the major driver of the global Buerger’s disease market.
The Americas can dominate the global Buerger’s disease market till 2030.
STEMPEUTICS RESEARCH PVT LTD, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., pluristem, Toshiba Medical Corporation, Shimadzu Corporation, t2cure GmbH, Siemens Healthcare GmbH, and General Electric Company are notable players of the global Buerger’s disease market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
